cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Zymeworks Inc
11 own
17 watching
Current Price
$9.12
$-0.26
(-2.83%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
550.51M
52-Week High
52-Week High
13.14000
52-Week Low
52-Week Low
6.01500
Average Volume
Average Volume
0.25M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization550.51M
icon52-Week High13.14000
icon52-Week Low6.01500
iconAverage Volume0.25M
iconDividend Yield--
iconP/E Ratio--
What does the Zymeworks Inc do?
N/A
Read More
How much money does Zymeworks Inc make?
News & Events about Zymeworks Inc.
Globe Newswire
10 months ago
VANCOUVER, British Columbia, July 03, 2023 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today announced that management will participate in the following upcoming investor conference: BTIG Virtual ...
Globe Newswire
10 months ago
VANCOUVER, British Columbia, June 26, 2023 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today announced that it is set to join both the Russell 3000, Russell 2000, and the Russell Microcap Indexes at the ...
PR Newswire
11 months ago
Thinking about buying stock in AMC Entertainment, Zymeworks, Tscan Therapeutics, SGHC Ltd, or Workhorse Group? Thinking about buying stock in AMC Entertainment, Zymeworks, Tscan Therapeutics, SGHC Ltd, or Workhorse Group? PR Newswire NEW YORK, June 22, 2023 NEW YORK, June 22, 2023 /PRNewswire...
InvestorPlace
11 months ago
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Sometimes you can get the best of both worlds in the equities sector, which should draw interest for these undervalued growth stocks. The post The 3 Most Undervalued Growth Stocks for Your June Buy List appeared first on InvestorPlace...
Globe Newswire
1 year ago
VANCOUVER, British Columbia, May 01, 2023 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today announced that management will participate in the following upcoming investor conferences: Bank of America ...
Frequently Asked Questions
Frequently Asked Questions
What is Zymeworks Inc share price today?
plus_minus_icon
Can Indians buy Zymeworks Inc shares?
plus_minus_icon
How can I buy Zymeworks Inc shares from India?
plus_minus_icon
Can Fractional shares of Zymeworks Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Zymeworks Inc stocks?
plus_minus_icon
What is today’s traded volume of Zymeworks Inc?
plus_minus_icon
What is today’s market capitalisation of Zymeworks Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Zymeworks Inc?
plus_minus_icon
What percentage is Zymeworks Inc down from its 52-Week High?
plus_minus_icon
What percentage is Zymeworks Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$9.12
$-0.26
(-2.83%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00